Mga Batayang Estadistika
| LEI | 549300LMT5KQQXCEZ733 |
| CIK | 75252 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Owens & Minor, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 11, 2025 |
EX-99.1 Exhibit 99.1 Owens & Minor Reports Second Quarter 2025 Financial Results Classified Products & Healthcare Services Segment as Discontinued Operations Continuing Operations, Patient Direct, Showed Solid Performance and Growth RICHMOND, VA – August 11, 2025 – Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2025. In connection with a like |
|
| August 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2025 Owens & Minor, Inc. |
|
| August 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 Owens & |
|
| August 11, 2025 |
EX-99.2 Second Quarter 2025 Continuing Operations Supplemental Earnings Slides August 11, 2025 Exhibit 99.2 Safe Harbor This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC’s Fair Disclosure Regulation. This release contains certain “forward looking” statements made pursuant to the Saf |
|
| June 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report: June 5, 2025 OWENS & MINOR, INC. |
|
| June 5, 2025 |
Exhibit 99.1 Owens & Minor and Rotech Healthcare Mutually Agree to Terminate Previously Announced Acquisition OMI Remains Committed to Continued Growth in the Strong Home-based Care Market Will Focus on Deleveraging & Driving Profitable Growth RICHMOND, VA – June 5, 2025 – Owens & Minor, Inc. (NYSE: OMI) today announced it has mutually agreed with Rotech Healthcare Holdings Inc. to terminate the p |
|
| June 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 (Date of earliest event reported) Date of Report: June 5, 2025 OWENS & MINOR, INC. |
|
| June 5, 2025 |
Exhibit 10.1 MUTUAL TERMINATION AGREEMENT MUTUAL TERMINATION AGREEMENT (this “Agreement”), dated as of June 3, 2025, by and among Rotech Healthcare Holdings Inc., a Delaware corporation (the “Company”), Owens & Minor, Inc., a Virginia corporation (“Parent”), and Hitchcock Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”). W I T N E S S E T H: WHEREAS, P |
|
| May 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report OWENS & MINOR, INC. (Exact name of registrant as specified in its charter) Virginia 001-9810 54-1701843 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 10900 Nuckols Road, Suite 400, Glen Allen, Virginia 23060 (Address of principal |
|
| May 28, 2025 |
EXHIBIT 1.01 Owens & Minor, Inc. Conflict Minerals Report For the Year Ended December 31, 2024 I. Introduction This Conflict Minerals Report (“Report”) by Owens & Minor, Inc. and subsidiaries (“Owens & Minor,” “Company,” “we,” “us,” and “our”) is for the period from January 1, 2024 to December 31, 2024 (“Reporting Period”). This Report is intended to comply with Rule 13p-1 of the Securities Exchan |
|
| May 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2025 Owens & Minor, Inc. |
|
| May 8, 2025 |
Exhibit 99.1 Owens & Minor Reports First Quarter 2025 Financial Results Top-Line Growth Led by the Patient Direct Segment Patient Direct Operating Margin Expanded by 173 Basis Points Company Reaffirmed 2025 Financial Guidance Remain Actively Engaged in Potential Sale of Products & Healthcare Services Segment RICHMOND, VA – May 8, 2025 – Owens & Minor, Inc. (NYSE: OMI) today reported financial resu |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Owens & Minor, Inc. |
|
| May 8, 2025 |
Exhibit 99.2 1 Confidential & Proprietary to Owens & Minor, Inc. First Quarter 2025 Supplemental Earnings Slides May 8, 2025 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC’s Fair Disclosure Regulation. This pres |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 Owens |
|
| April 4, 2025 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2025 OWENS & MINOR, INC. |
|
| April 4, 2025 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidenti |
|
| April 4, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement |
|
| April 4, 2025 |
Exhibit 4.1 OWENS & MINOR, INC., the GUARANTORS party hereto from time to time AND REGIONS BANK, as Trustee and Notes Collateral Agent 10.000% Senior Secured Notes due 2030 INDENTURE Dated as of April 4, 2025 Table of Contents Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE SECTION 1.1 Definitions 1 SECTION 1.2 Other Definitions 71 SECTION 1.3 [Reserved] 75 SECTION 1.4 Rules of Construct |
|
| April 2, 2025 |
Exhibit 99.1 Owens & Minor Announces Upsize and Pricing of Senior Secured Notes Offering April 2, 2025 RICHMOND, Va. — (BUSINESS WIRE) — Owens & Minor, Inc. (NYSE:OMI) (the “Company”) announced today the upsize and pricing of its private offering (the “Offering”) of $1 billion aggregate principal amount of its 10.000% senior secured notes due 2030 (the “Notes”). The Offering is expected to close o |
|
| April 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(D) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 2, 2025 OWENS & MINOR, INC. (Exact name of Registrant as specified in charter) Virginia 001-09810 54-1701843 (State or other jurisdiction of incorporation) (Commission file numb |
|
| March 26, 2025 |
OWENS & MINOR, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.5 OWENS & MINOR, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On July 22, 2024, Owens & Minor, Inc., a Virginia corporation (“Owens & Minor”, the “Company”, “we”, “our”), entered into an Agreement and Plan of Merger (the “Acquisition Agreement”) by and among the Company, Rotech Healthcare Holdings Inc., a Delaware corporation (“Rotech”), Hitchcock Merger Sub Inc., a |
|
| March 26, 2025 |
Owens & Minor Announces Launch of Senior Secured Notes Offering Exhibit 99.1 Owens & Minor Announces Launch of Senior Secured Notes Offering March 26, 2025 RICHMOND, Va.—(BUSINESS WIRE)— Owens & Minor, Inc. (NYSE:OMI) (the “Company”) announced today that it has launched a private offering (the “Offering”) of $600 million aggregate principal amount of senior secured notes due 2030 (the “Notes”), subject to customary and market conditions. Unless the previously |
|
| March 26, 2025 |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF RHI Exhibit 99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF RHI RHI and its subsidiaries are referred to as the “Company,” “our,” or “we,” in this section. The discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and related notes as of and fo |
|
| March 26, 2025 |
Exhibit 99.4 ROTECH’S BUSINESS The following discussion of the business of Rotech (referred to as the “Company,” “our,” or “we” in this discussion) and its subsidiaries should be read in conjunction with our audited consolidated financial statements and related notes as of and for the years ended December 31, 2024 and 2023. In addition to historical information, this discussion contains forward-lo |
|
| March 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 26, 2025 OWENS & MINOR, INC. |
|
| March 26, 2025 |
Exhibit 99.3 Risks Related to Rotech’s Business and Operations In the following discussion of Risks Related to Rotech’s Business and Operations, the “Company,” “our,” or “we” refer to Rotech Healthcare Holdings Inc. and its subsidiaries. We depend on reimbursements by payors, which can and do change fee schedules, contract terms, reimbursement rules and standards of care, which can lead to lower r |
|
| March 26, 2025 |
Exhibit 99.6 ROTECH HEALTHCARE INC. AND SUBSIDIARIES INDEX TO ANNUAL CONSOLIDATED FINANCIAL STATEMENTS Page Independent Auditor’s Report 2 Consolidated Financial Statements Consolidated Balance Sheets 3 Consolidated Statements of Operations 4 Consolidated Statements of Comprehensive Income 5 Consolidated Statements of Changes in Stockholders’ Equity 6 Consolidated Statements of Cash Flows 7 Notes |
|
| March 20, 2025 |
Lender Presentation March 20, 2025 Proprietary to Owens & Minor, Inc. © 2025 Owens & Minor, Inc. Exhibit 99.1 Disclaimer Forward-Looking Statements This presentation contains certain “forward-looking” statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Some of these statements can be identified by terms and phrases such as “outlook,” “bel |
|
| March 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2025 Owens & Minor, Inc. (Exact Name of Registrant as Specified in its Charter) Virginia 001-09810 54-1701843 (State or other jurisdiction of incorporation or organization) |
|
| February 28, 2025 |
Description of Securities - filed herewith Exhibit 4.14 DESCRIPTION OF THE COMPANY’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a brief description of the common stock, $2.00 par value per share (the “Common Stock”), of Owens & Minor, Inc. (the “Company,” “we,” “us,” and “our”), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Ac |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2025 Owens & Minor, Inc. |
|
| February 28, 2025 |
Exhibit 21.1 Subsidiaries of Registrant State of Incorporation/ Subsidiary Organization Country Assumed Name American Contract Systems, Inc. Minnesota USA AVID Medical, Inc. Delaware USA Barista Acquisition I, LLC Virginia USA Barista Acquisition II, LLC Virginia USA Byram Healthcare Centers, Inc. New Jersey USA Byram Holdings I, Inc. New Jersey USA Clinical Care Services, L.L.C. Utah USA Diabetes |
|
| February 28, 2025 |
Owens & Minor, Inc. Officer Severance Policy dated February 27, 2025* - filed herewith Owens & Minor, Inc. Officer Severance Policy Organizational or Functional Area(s): Corporate Officers Policy For: Officer Severance Sponsor: The Our People & Culture Committee of the Board of Directors 1.0 Approval, Review and Revision History Version Description of Revision Stakeholder/ Reviewer Date Title Original Policy Adopted 2005 Board of Directors Approved 2015 Board of Directors Approved |
|
| February 28, 2025 |
Form of Amended and Restated Executive Change of Control Severance Agreement* - filed herewith [AMENDED AND RESTATED] EXECUTIVE CHANGE OF CONTROL SEVERANCE AGREEMENT [Exec Name] [Exec title] [Address] Dear []: Owens & Minor, Inc. |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the year ended December 31, 2024 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 1-9810 OWENS & MINOR, INC. ( |
|
| February 28, 2025 |
Exhibit 99.1 Owens & Minor Reports Fourth Quarter & Full Year Financial Results and Announces Sale Process Underway for Products & Healthcare Services Segment Total Debt Reduction of $244 Million in 2024, Capping a Two-Year Total Debt Reduction of $647 Million 2025 Guidance Midpoint Indicates Double-Digit Adjusted EBITDA & Adjusted EPS Growth, and Improving Cash Flow Active Discussions Well Underw |
|
| February 28, 2025 |
Exhibit 19.1 OWENS & MINOR, INC. Section 16 and Insider Trading Compliance Policy Amended and Restated Effective February 27, 2023 TABLE OF CONTENTS Page -i-I. INTRODUCTION.................................................................................................................. 1 II. SECTION 16 COMPLIANCE...................................................................................... |
|
| February 28, 2025 |
Exhibit 99.2 1 Confidential & Proprietary to Owens & Minor, Inc. Fourth Quarter 2024 Supplemental Earnings Slides February 28, 2025 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC’s Fair Disclosure Regulation. Th |
|
| February 3, 2025 |
EX-99.1 Exhibit 99.1 Owens & Minor Launches Financing for Rotech Acquisition and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Results Ahead of Investor Meetings Expects to Report Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025 RICHMOND, VA – February 3, 2025 – Owens & Minor, Inc. (NYSE: OMI) (the “Company”) today announced selected preliminary financial |
|
| February 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2025 Owens & Minor, Inc. (Exact Name of Registrant as Specified in its Charter) Virginia 001-09810 54-1701843 (State or other jurisdiction of incorporation or organization |
|
| February 3, 2025 |
Today’s Presenter Jon Leon EVP, Chief Financial Officer Proprietary to Owens & Minor, Inc. EX-99.2 Lender Presentation February 2025 Proprietary to Owens & Minor, Inc. © 2025 Owens & Minor, Inc. Exhibit 99.2 Disclaimer This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This presentation contains certain “forward-looking” statements made p |
|
| December 27, 2024 |
Joint Filing Agreement Pursuant to Rule 13d-1 EXHIBIT 1 Joint Filing Agreement Pursuant to Rule 13d-1 This agreement is made pursuant to Rule 13d-l(k)(1) under the Securities and Exchange Act of 1934, as amended (the “Act”) by and among the parties listed below, each referenced to herein as a “Joint Filer. |
|
| November 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2024 Owens & Minor, Inc. |
|
| November 4, 2024 |
Exhibit 99.2 1 Confidential & Proprietary to Owens & Minor, Inc. Third Quarter 2024 Supplemental Earnings Slides November 4, 2024 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This |
|
| November 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 Ow |
|
| November 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2024 Owens & Minor, Inc. |
|
| November 4, 2024 |
Exhibit 99.1 Owens & Minor Reports Third Quarter 2024 Financial Results Top-Line Growth Driven by Continued Solid Demand in Patient Direct and Medical Distribution Total Debt Reduction of Nearly $200 Million in the Third Quarter RICHMOND, VA – November 4, 2024 – Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2024. Key Highlights: ● Consol |
|
| October 22, 2024 |
Exhibit 10.1 EXECUTION VERSION RECEIVABLES PURCHASE AGREEMENT Dated as of October 18, 2024 by and among O&M FUNDING LLC, as Seller, THE PERSONS FROM TIME TO TIME PARTY HERETO, as Purchasers, PNC BANK, NATIONAL ASSOCIATION, as Administrative Agent, OWENS & MINOR MEDICAL, LLC, as initial Servicer, and PNC CAPITAL MARKETS LLC, as Structuring Agent TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 2 SEC |
|
| October 22, 2024 |
Exhibit 10.3 EXECUTION VERSION AMENDED AND RESTATED PERFORMANCE GUARANTY This AMENDED AND RESTATED PERFORMANCE GUARANTY (as amended, supplemented or otherwise modified from time to time, this “Performance Guaranty”), dated as of October 18, 2024, is made by OWENS & MINOR, INC. (the “Performance Guarantor”), a Virginia corporation, in favor of PNC BANK, NATIONAL ASSOCIATION (“PNC”), as administrati |
|
| October 22, 2024 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2024 OWENS & MINOR, INC. (Exact name of Registrant as specified in its charter) Virginia 001-09810 54-1701843 (State or other jurisdiction of incorporation) (Commission fi |
|
| October 22, 2024 |
Exhibit 10.2 EXECUTION VERSION AMENDED AND RESTATED PURCHASE AND SALE AGREEMENT Dated as of October 18, 2024 among VARIOUS ENTITIES LISTED ON SCHEDULE I HERETO, as Originators, OWENS & MINOR MEDICAL, LLC, as Servicer, and O&M FUNDING LLC, as Buyer CONTENTS Clause Subject Matter Page ARTICLE I AGREEMENT TO PURCHASE AND SELL 2 SECTION 1.1 Agreement To Purchase and Sell 2 SECTION 1.2 Timing of Purcha |
|
| October 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 11, 2024 OWENS & MINOR, INC. |
|
| September 23, 2024 |
Owens & Minor Names Jonathan Leon Executive Vice President, Chief Financial Officer Exhibit 99.1 Owens & Minor Names Jonathan Leon Executive Vice President, Chief Financial Officer RICHMOND, VA —September 23, 2024 — Owens & Minor, Inc. (NYSE: OMI), announced today that Mr. Jonathan Leon has been named Executive Vice President, Chief Financial Officer, effective immediately. Leon will maintain his corporate treasurer responsibilities while a search for his successor is underway. M |
|
| September 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 23, 2024 OWENS & MINOR, INC. (Exact name of Registrant as specified in charter) Virginia 001-09810 54-1701843 (State or other jurisdiction of incorporation) (Commission file |
|
| September 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 16, 2024 OWENS & MINOR, INC. |
|
| August 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 Owens & |
|
| August 2, 2024 |
Exhibit 10.1 EXECUTION VERSION EXECUTIVE TRANSITION & GENERAL RELEASE AGREEMENT This Executive Transition & General Release Agreement (this Agreement between Alexander J. Bruni all Related Entities (as defined herein) O&M Company . Executive and O&M are each referred to herein as Party and, collectively, as Parties. WHEREAS, Executive is employed by the Company as its Executive Vice President and |
|
| August 2, 2024 |
List of Subsidiaries Pledged as Collateral Exhibit 22.2 Owens & Minor, Inc. List of Subsidiaries Pledged as Collateral The following table lists the pledged subsidiaries of Owens & Minor, Inc.’s 2024 Notes that constitute collateral (together, “the Collateral Group”) as of June 30, 2024: Entity Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard |
|
| August 2, 2024 |
Exhibit 99.1 Owens & Minor Reports Second Quarter 2024 Financial Results Top Line Expansion Driven by Solid Growth in Both Segments Second Quarter Operating Cash Flow of $116 Million Drove $71 million in Debt Reduction Expanding Patient Direct Segment with Agreement to Acquire Rotech Healthcare Holdings RICHMOND, VA – August 2, 2024 – Owens & Minor, Inc. (NYSE: OMI) today reported financial result |
|
| August 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2024 Owens & Minor, Inc. |
|
| August 2, 2024 |
Exhibit 99.2 1 Confidential & Proprietary to Owens & Minor, Inc. Second Quarter 2024 Supplemental Earnings Slides August 2, 2024 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This |
|
| August 2, 2024 |
List of Guarantor Subsidiaries Exhibit 22.1 Owens & Minor, Inc. List of Guarantor Subsidiaries The following table lists the guarantors, issuers, or co-issuers of Owens & Minor, Inc.'s 2024 Notes as of June 30, 2024: Entity: Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard, Inc. O&M Byram Holding, GP Byram Holdings I, Inc. Byram H |
|
| July 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2024 OWENS & MINOR, INC. |
|
| July 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2024 OWENS & MINOR, INC. |
|
| July 23, 2024 |
Exhibit 99.2 Rotech – Investor Presentation July 23, 2024 Disclaimer This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This presentation contains certain “forward-looking” statements made pursuant to the Safe Harbor provisions of the Private Securi |
|
| July 23, 2024 |
Exhibit 99.1 Owens & Minor, Inc. Releases Preliminary Second Quarter 2024 Financial Results & Reaffirms 2024 Annual Guidance Plans to Release Full Results on Friday, August 2 Before the NYSE Open RICHMOND, VA – July 23, 2024 – Owens & Minor, Inc. (NYSE: OMI) today announced selected preliminary financial results for the quarter ended June 30, 2024 as noted in the table below. The Company also reaf |
|
| July 23, 2024 |
Exhibit 99.1 Owens & Minor, Inc. Signs Definitive Agreement to Acquire Rotech Healthcare Holdings, Inc. for $1.36 Billion in Cash Strategy Articulated at Investor Day is Advanced by Strengthening Our Patient Direct’s Position as a Premier Growth Platform in Home-Based Care Combined Capabilities Support Improved Service to Patients, Providers, and Payors Adjusted EPS Neutral in First Full Year and |
|
| July 23, 2024 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2024 OWENS & MINOR, INC. |
|
| July 23, 2024 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER BY AND AMONG OWENS & MINOR, INC., HITCHCOCK MERGER SUB INC., ROTECH HEALTHCARE HOLDINGS INC., AND SHAREHOLDER REPRESENTATIVE SERVICES LLC, IN ITS CAPACITY AS THE REPRESENTATIVE, DATED AS OF July 22, 2024 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 1.1 Definitions 1 1.2 Other Capitalized Terms 20 1.3 Interpretive Provisions 21 ARTICLE 2 THE MERGER 22 2.1 |
|
| June 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 21, 2024 OWENS & MINOR, INC. (Exact name of Registrant as specified in charter) Virginia 001-09810 54-1701843 (State or other jurisdiction of incorporation) (Commission file numb |
|
| May 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report OWENS & MINOR, INC. (Exact name of registrant as specified in its charter) Virginia 001-9810 54-1701843 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 9120 Lockwood Boulevard, Mechanicsville, Virginia 23116 (Address of principal ex |
|
| May 30, 2024 |
EXHIBIT 1.01 Owens & Minor, Inc. Conflict Minerals Report For the Year Ended December 31, 2023 I. Introduction This Conflict Minerals Report (“Report”) by Owens & Minor, Inc. and subsidiaries (“Owens & Minor,” “Company,” “we,” “us,” and “our”) is for the period from January 1, 2023 to December 31, 2023 (“Reporting Period”). This Report is intended to comply with Rule 13p-1 of the Securities Exchan |
|
| May 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2024 Owens & Minor, Inc. |
|
| May 10, 2024 |
As filed with the Securities and Exchange Commission on May 10, 2024 As filed with the Securities and Exchange Commission on May 10, 2024 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OWENS & MINOR, INC. (Exact name of registrant as specified in its charter) Virginia 54-1701843 (State or other jurisdiction of incorporation or organization) (IRS Employer Identificatio |
|
| May 10, 2024 |
Filing Fees Table (filed herewith) Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Owens & Minor, Inc. |
|
| May 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 Owens & Minor, Inc. |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 Owens & Minor, Inc. |
|
| May 3, 2024 |
List of Subsidiaries Pledged as Collateral Exhibit 22.2 Owens & Minor, Inc. List of Subsidiaries Pledged as Collateral The following table lists the pledged subsidiaries of Owens & Minor, Inc.’s 2024 Notes that constitute collateral (together, “the Collateral Group”) as of March 31, 2024: Entity Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyar |
|
| May 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 Owens |
|
| May 3, 2024 |
Exhibit 99.2 1 Confidential & Proprietary to Owens & Minor, Inc. First Quarter 2024 Supplemental Earnings Slides May 3, 2024 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This pres |
|
| May 3, 2024 |
Exhibit 99.1 Owens & Minor Reports First Quarter 2024 Financial Results Gross Margin Expansion of 79 Basis Points Adjusted EPS Growth of Nearly Four Times with GAAP EPS Loss of $(0.29) and Adjusted EPS of $0.19 Investments Outlined at 2023 Investor Day for Long-Term Growth are Ahead of Plan RICHMOND, VA – May 3, 2024 – Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first |
|
| May 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2024 Owens & Minor, Inc. |
|
| May 3, 2024 |
List of Guarantor Subsidiaries Exhibit 22.1 Owens & Minor, Inc. List of Guarantor Subsidiaries The following table lists the guarantors, issuers, or co-issuers of Owens & Minor, Inc.'s 2024 Notes as of March 31, 2024: Entity: Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard, Inc. O&M Byram Holding, GP Byram Holdings I, Inc. Byram |
|
| April 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 16, 2024 OWENS & MINOR, INC. (Exact name of Registrant as specified in charter) Virginia 001-09810 54-1701843 (State or other jurisdiction of incorporation) (Commission file num |
|
| March 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for |
|
| March 27, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement |
|
| March 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2024 Owens & Minor, Inc. |
|
| March 1, 2024 |
OWENS & MINOR, INC. 2023 Omnibus Incentive Plan PERFORMANCE STOCK UNIT GRANT NOTICE Pursuant to the terms and conditions of the Owens & Minor, Inc. 2023 Omnibus Incentive Plan, as amended from time to time (the “Plan”), Owens & Minor, Inc., a Virginia corporation (the “Company”), hereby grants to the individual listed below (“you” or the “Participant”) the number of performance-based stock units ( |
|
| February 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the year ended December 31, 2023 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 1-9810 OWENS & MINOR, INC. ( |
|
| February 20, 2024 |
Owens & Minor, Inc. Policy on Recoupment of Executive Incentive Compensation Exhibit 97 OWENS & MINOR, INC. POLICY ON RECOUPMENT OF EXECUTIVE INCENTIVE COMPENSATION PURPOSE The Board of Directors (the “Board”) of Owens & Minor, Inc. (the “Company”) believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation philo |
|
| February 20, 2024 |
Exhibit 99.2 1 Confidential & Proprietary to Owens & Minor, Inc. Fourth Quarter 2023 Supplemental Earnings Slides February 20, 2024 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. Th |
|
| February 20, 2024 |
Exhibit 99.1 Owens & Minor Reports Fourth Quarter and Full Year 2023 Financial Results Business Delivered Strong Operating Margin Improvement in Fourth Quarter Robust Full Year Operating Cash Flow Generation Enabled Significant Debt Reduction RICHMOND, VA – February 20, 2024 – Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2023. |
|
| February 20, 2024 |
List of Subsidiaries Pledged as Collateral Exhibit 22.2 Owens & Minor, Inc. List of Subsidiaries Pledged as Collateral The following table lists the pledged subsidiaries of Owens & Minor, Inc.’s 2024 Notes that constitute collateral (together, "the Collateral Group") as of December 31, 2023: Entity Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Hal |
|
| February 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2024 Owens & Minor, Inc. |
|
| February 20, 2024 |
Exhibit 21.1 Subsidiaries of Registrant State of Incorporation/ Subsidiary Organization Country Assumed Name American Contract Systems, Inc. Minnesota USA AVID Medical, Inc. Delaware USA Barista Acquisition I, LLC Virginia USA Barista Acquisition II, LLC Virginia USA Byram Healthcare Centers, Inc. New Jersey USA Byram Holdings I, Inc. New Jersey USA Clinical Care Services, L.L.C. Utah USA Diabetes |
|
| February 20, 2024 |
Description of Securities - filed herewith Exhibit 4.14 DESCRIPTION OF THE COMPANY’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a brief description of the common stock, $2.00 par value per share (the “Common Stock”), of Owens & Minor, Inc. (the “Company,” “we,” “us,” and “our”), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Ac |
|
| February 20, 2024 |
List of Guarantor Subsidiaries Exhibit 22.1 Owens & Minor, Inc. List of Guarantor Subsidiaries The following table lists the guarantors, issuers, or co-issuers of Owens & Minor, Inc.'s 2024 Notes as of December 31, 2023: Entity: Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard, Inc. O&M Byram Holding, GP Byram Holdings I, Inc. Byr |
|
| February 13, 2024 |
OMI / Owens & Minor, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01639-owensminorinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 17)* Name of issuer: Owens & Minor Inc Title of Class of Securities: Common Stock CUSIP Number: 690732102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate t |
|
| February 12, 2024 |
OMI / Owens & Minor, Inc. / Flynn James E Passive Investment SC 13G/A 1 e619248sc13ga-om.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1) * Owens & Minor, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 690732102 (CUSIP Number) December 31, 2023 |
|
| February 9, 2024 |
OMI / Owens & Minor, Inc. / DIMENSIONAL FUND ADVISORS LP - SEC SCHEDULE 13G Passive Investment SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Owens & Minor Inc (Name of Issuer) Common Stock (Title of Class of Securities) 690732102 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig |
|
| December 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 11, 2023 OWENS & MINOR, INC. (Exact name of Registrant as specified in charter) Virginia 001-09810 54-1701843 (State or other jurisdiction of incorporation) (Commission file |
|
| December 6, 2023 |
Owens & Minor Unveils Long-Term Strategy at Investor Day Today Outlines new five-year strategic plan intended to unlock expanded profitability and growth profiles of the business, targeting 20% compounded earnings growth between 2024 to 2028 Investments and strong cash generation expectations are anticipated to support multi-faceted growth and a value-enhancing capital allocation program RICHMOND, VA – December 6, 2023 – Owens & Minor, Inc. |
|
| December 6, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2023 Owens & Minor, Inc. |
|
| December 6, 2023 |
Exhibit 99.2 I N V E S T O R D A Y D e c e m b e r 6 , 2 0 2 3 Proprietary to Owens & Minor, Inc. | ©2023 Owens & Minor, Inc. 2 Jon Leon Senior Vice President & Corporate Treasurer Owens & Minor Proprietary to Owens & Minor, Inc. 3 This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the |
|
| November 9, 2023 |
OMI / Owens & Minor, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Owens & Minor, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 690732102 (CUSIP Number) October 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| November 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 Ow |
|
| November 3, 2023 |
List of Guarantor Subsidiaries Exhibit 22.1 Owens & Minor, Inc. List of Guarantor Subsidiaries The following table lists the guarantors, issuers, or co-issuers of Owens & Minor, Inc.'s 2024 Notes as of September 30, 2023: Entity: Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard, Inc. O&M Byram Holding, GP Byram Holdings I, Inc. By |
|
| November 3, 2023 |
List of Subsidiaries Pledged as Collateral Exhibit 22.2 Owens & Minor, Inc. List of Subsidiaries Pledged as Collateral The following table lists the pledged subsidiaries of Owens & Minor, Inc.’s 2024 Notes that constitute collateral (together, "the Collateral Group") as of September 30, 2023: Entity Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Ha |
|
| November 3, 2023 |
omi3q23supplementalearn 1 Confidential & Proprietary to Owens & Minor, Inc. Third Quarter 2023 Supplemental Earnings Slides November 3, 2023 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regul |
|
| November 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2023 Owens & Minor, Inc. |
|
| November 3, 2023 |
Owens & Minor Reports Third Quarter 2023 Financial Results Top Line Expansion Led by Healthy Demand in Patient Direct and Medical Distribution Operating Cash Flow Generation Supported $188 million in Total Debt Reduction RICHMOND, VA – November 3, 2023 – Owens & Minor, Inc. |
|
| August 4, 2023 |
omi2q23supplementalearn 1 Confidential & Proprietary to Owens & Minor, Inc. Second Quarter 2023 Supplemental Earnings Slides August 4, 2023 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regula |
|
| August 4, 2023 |
List of Subsidiaries Pledged as Collateral Exhibit 22.2 Owens & Minor, Inc. List of Subsidiaries Pledged as Collateral The following table lists the pledged subsidiaries of Owens & Minor, Inc.’s 2024 Notes that constitute collateral (together, "the Collateral Group") as of June 30, 2023: Entity Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard |
|
| August 4, 2023 |
Owens & Minor Reports Second Quarter 2023 Financial Results Top-line Growth Driven by Strong Performance in Patient Direct Operating Model Realignment Program Remains on Track Operating Cash Flow of $313 Million, Inclusive of $115 Million in Receivables Sales RICHMOND, VA – August 4, 2023 – Owens & Minor, Inc. |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2023 Owens & Minor, Inc. |
|
| August 4, 2023 |
List of Guarantor Subsidiaries Exhibit 22.1 Owens & Minor, Inc. List of Guarantor Subsidiaries The following table lists the guarantors, issuers, or co-issuers of Owens & Minor, Inc.'s 2024 Notes as of June 30, 2023: Entity: Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard, Inc. O&M Byram Holding, GP Byram Holdings I, Inc. Byram H |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 Owens & |
|
| June 6, 2023 |
May 23, 2023 United States Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, N. |
|
| May 31, 2023 |
EX-1.01 2 exh101-omcmr2022.htm EX-1.01 EXHIBIT 1.01 Owens & Minor, Inc. Conflict Minerals Report For the Year Ended December 31, 2022 I. Introduction This Conflict Minerals Report (“Report”) by Owens & Minor, Inc. and subsidiaries (“Owens & Minor,” “Company,” “we,” “us,” and “our”) is for the period from January 1, 2022 to December 31, 2022 (“Reporting Period”). This Report is intended to comply w |
|
| May 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report OWENS & MINOR, INC. (Exact name of registrant as specified in its charter) Virginia 001-9810 54-1701843 (State or other jurisdiction of incorporation (Commission File Number) (IRS Employer Identification No.) 9120 Lockwood Boulevard, Mechanicsville, Virginia 23116 (Address of principal exe |
|
| May 12, 2023 |
As filed with the Securities and Exchange Commission on May 12, 2023 As filed with the Securities and Exchange Commission on May 12, 2023 No. 333-264671 No. 333-251376 No. 333-238059 No. 333-231386 No. 333-224787 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-264671 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-251376 POST-EFFECTIVE AMENDMENT |
|
| May 12, 2023 |
OWENS & MINOR, INC. 2023 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT GRANT NOTICE Pursuant to the terms and conditions of the Owens & Minor, Inc. 2023 Omnibus Incentive Plan, as amended from time to time (the “Plan”), Owens & Minor, Inc., a Virginia corporation (the “Company”), hereby grants to the individual listed below (“you” or the “Participant”) the number of restricted stock units (the “Res |
|
| May 12, 2023 |
Filing Fees Table (filed herewith) EX-FILING FEES 2 exhibit107filingfees.htm EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Owens & Minor, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amou |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2023 Owens & Minor, Inc. |
|
| May 12, 2023 |
OWENS & MINOR, INC. 2023 OMNIBUS INCENTIVE PLAN NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT GRANT NOTICE Pursuant to the terms and conditions of the Owens & Minor, Inc. 2023 Omnibus Incentive Plan, as amended from time to time (the “Plan”), Owens & Minor, Inc., a Virginia corporation (the “Company”), hereby grants to the individual listed below (“you” or the “Participant”) the number of restricted |
|
| May 12, 2023 |
As filed with the Securities and Exchange Commission on May 12, 2023 As filed with the Securities and Exchange Commission on May 12, 2023 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OWENS & MINOR, INC. (Exact name of registrant as specified in its charter) Virginia 54-1701843 (State or other jurisdiction of incorporation or organization) (IRS Employer Identificatio |
|
| May 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2023 Owens & Minor, Inc. |
|
| May 5, 2023 |
List of Guarantor Subsidiaries Exhibit 22.1 Owens & Minor, Inc. List of Guarantor Subsidiaries The following table lists the guarantors, issuers, or co-issuers of Owens & Minor, Inc.'s 2024 Notes as of March 31, 2023: Entity: Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard, Inc. O&M Byram Holding, GP Byram Holdings I, Inc. Byram |
|
| May 5, 2023 |
pnc-owensminorxfifthamen EXECUTION VERSION 751248203 19620050 FIFTH AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT This FIFTH AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT (this “Amendment”), dated as of March 14, 2023, is entered into by and among the following parties: (i) O&M FUNDING LLC, as Borrower (the “Borrower”); (ii) OWENS & MINOR MEDICAL, INC. |
|
| May 5, 2023 |
omi1q23supplementalearn 1 Confidential & Proprietary to Owens & Minor, Inc. First Quarter 2023 Supplemental Earnings Slides May 5, 2023 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation |
|
| May 5, 2023 |
List of Subsidiaries Pledged as Collateral Exhibit 22.2 Owens & Minor, Inc. List of Subsidiaries Pledged as Collateral The following table lists the pledged subsidiaries of Owens & Minor, Inc.’s 2024 Notes that constitute collateral (together, "the Collateral Group") as of March 31, 2023: Entity Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyar |
|
| May 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 Owens |
|
| May 5, 2023 |
Owens & Minor Reports First Quarter 2023 Financial Results Strength of Patient Direct Drove Gross Margin Expansion Operating Model Realignment Program Remains on Track Raised Midpoint of 2023 Guidance Based on Strong Patient Direct Performance and Profit Improvement Efforts RICHMOND, VA – May 5, 2023 – Owens & Minor, Inc. |
|
| April 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 13, 2023 OWENS & MINOR, INC. (Exact name of Registrant as specified in charter) Virginia 001-09810 54-1701843 (State or other jurisdiction of incorporation) (Commission file num |
|
| April 17, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2023 Owens & Minor, Inc. |
|
| April 17, 2023 |
The unaudited reclassified financial information and recast non-GAAP information below is provided to reflect the changes in the Owens & Minor, Inc. |
|
| April 6, 2023 |
OMI / Owens & Minor, Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| March 29, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid |
|
| March 29, 2023 |
DEFA14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the year ended December 31, 2022 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 1-9810 OWENS & MINOR, INC. (Exact name of regi |
|
| February 28, 2023 |
List of Guarantor Subsidiaries EX-22.1 4 exhibit221-guarantorsubs12.htm EX-22.1 Exhibit 22.1 Owens & Minor, Inc. List of Guarantor Subsidiaries The following table lists the guarantors, issuers, or co-issuers of Owens & Minor, Inc.'s 2024 Notes as of December 31, 2022: Entity: Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard, Inc. |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 Owens & Minor, Inc. |
|
| February 28, 2023 |
Exhibit 21.1 Subsidiaries of Registrant Subsidiary State of Incorporation/Organization Country Assumed Name American Contract Systems, Inc. Minnesota USA AVID Medical, Inc. Delaware USA Barista Acquisition I, LLC Virginia USA Barista Acquisition II, LLC Virginia USA Byram Healthcare Centers, Inc. New Jersey USA Byram Holdings I, Inc. New Jersey USA Clinical Care Services, L.L.C. Utah USA Diabetes |
|
| February 28, 2023 |
List of Subsidiaries Pledged as Collateral Exhibit 22.2 Owens & Minor, Inc. List of Subsidiaries Pledged as Collateral The following table lists the pledged subsidiaries of Owens & Minor, Inc.’s 2024 Notes that constitute collateral (together, "the Collateral Group") as of December 31, 2022: Entity Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Hal |
|
| February 28, 2023 |
Description of Securities - filed herewith DESCRIPTION OF THE COMPANY’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a brief description of the common stock, $2. |
|
| February 28, 2023 |
Owens & Minor Reports Fourth Quarter and Full Year 2022 Financial Results •Patient Direct Q4 revenue up 135%, or 10. |
|
| February 28, 2023 |
omi4q22supplementalearn 1 Confidential & Proprietary to Owens & Minor, Inc. Fourth Quarter and Full Year 2022 Supplemental Earnings Slides February 28, 2023 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair |
|
| February 9, 2023 |
OMI / Owens & Minor, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01608-owensminorinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 16)* Name of issuer: Owens & Minor Inc. Title of Class of Securities: Common Stock CUSIP Number: 690732102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate |
|
| February 6, 2023 |
OMI / Owens & Minor, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Owens & Minor, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 690732102 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 Ow |
|
| November 2, 2022 |
EXECUTIVE SEPARATION AGREEMENT & GENERAL RELEASE This Executive Separation Agreement & General Release (the ?Agreement?) is entered into as of the Effective Date (as defined below), by and between Jeffrey T. |
|
| November 2, 2022 |
List of Subsidiaries Pledged as Collateral Exhibit 22.2 Owens & Minor, Inc. List of Subsidiaries Pledged as Collateral The following table lists the pledged subsidiaries of Owens & Minor, Inc.?s 2024 Notes that constitute collateral (together, "the Collateral Group") as of September 30, 2022: Entity Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Ha |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2022 Owens & Minor, Inc. |
|
| November 2, 2022 |
AMENDED AND RESTATED BYLAWS OF OWENS & MINOR, INC. Article I Meetings of Shareholders 1.1 Places of Meetings. All meetings of the shareholders shall be held at such place either within or without the Commonwealth of Virginia, or in whole or in part by means of remote communication, in each case as from time to time may be fixed by the Board of Directors. 1.2 Annual Meetings. The annual meeting of |
|
| November 2, 2022 |
1 Third Quarter 2022 Supplemental Earnings Slides November 2, 2022 2 Confidential & Proprietary to Owens & Minor, Inc. |
|
| November 2, 2022 |
List of Guarantor Subsidiaries Exhibit 22.1 Owens & Minor, Inc. List of Guarantor Subsidiaries The following table lists the guarantors, issuers, or co-issuers of Owens & Minor, Inc.'s 2024 Notes as of September 30, 2022: Entity: Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard, Inc. O&M Byram Holding, GP Byram Holdings I, Inc. By |
|
| November 2, 2022 |
Owens & Minor Reports Third Quarter 2022 Financial Results Adjusted EBITDA of $127 million, margin up 140 basis points Patient Direct Revenue Growth of 142%, or 11. |
|
| October 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 12, 2022 OWENS & MINOR, INC. (Exact name of Registrant as specified in charter) Virginia 001-09810 54-1701843 (State or other jurisdiction of incorporation) (Commission file n |
|
| October 12, 2022 |
Exhibit 99.1 Owens & Minor Announces Executive Leadership Team Changes Company also Provides Preliminary Results for the 3rd Quarter and Updated Guidance for 2022 RICHMOND, VA ? October 12, 2022 ? Owens & Minor, Inc. (NYSE-OMI) today announced certain changes to its executive leadership team, including the appointment of Andrew G. Long as EVP, CEO, Products & Healthcare Services segment, replacing |
|
| September 13, 2022 |
1 Confidential & Proprietary to Owens & Minor, Inc. Ed Pesicka CEO Andy Long CFO 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This presentation contains certain ''forward-looking' |
|
| September 13, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2022 Owens & Minor, Inc. |
|
| August 3, 2022 |
List of Subsidiaries Pledged as Collateral Exhibit 22.2 Owens & Minor, Inc. List of Subsidiaries Pledged as Collateral The following table lists the pledged subsidiaries of Owens & Minor, Inc.?s 2024 Notes that constitute collateral (together, "the Collateral Group") as of June 30, 2022: Entity Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard |
|
| August 3, 2022 |
Owens & Minor Reports Second Quarter 2022 Financial Results ?Continued strength in Patient Direct with strong organic growth and acquisition synergies on track ?Delivered Q2 adjusted EBITDA of $156 million ?Weaker economic conditions and hospital volumes lead to new FY22 Adj. |
|
| August 3, 2022 |
List of Guarantor Subsidiaries Exhibit 22.1 Owens & Minor, Inc. List of Guarantor Subsidiaries The following table lists the guarantors, issuers, or co-issuers of Owens & Minor, Inc.'s 2024 Notes as of June 30, 2022: Entity: Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard, Inc. O&M Byram Holding, GP Byram Holdings I, Inc. Byram H |
|
| August 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 Owens & |
|
| August 3, 2022 |
1 Confidential & Proprietary to Owens & Minor, Inc. Second Quarter 2022 Supplemental Earnings Slides August 3, 2022 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This presentation |
|
| August 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2022 Owens & Minor, Inc. |
|
| July 12, 2022 |
Owens & Minor Elects Carissa Rollins to Board of Directors Owens & Minor continues multi-year Board succession process RICHMOND, Va. |
|
| July 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 12, 2022 Owens & Minor, Inc. |
|
| June 1, 2022 |
Amended and Restated Bylaws of the Company effective AMENDED AND RESTATED BYLAWS OF OWENS & MINOR, INC. ARTICLE I Meetings of Shareholders 1.1 Places of Meetings. All meetings of the shareholders shall be held at such place either within or without the Commonwealth of Virginia, or at no physical place but solely by means of remote communication, in each case as from time to time may be fixed by the Board of Directors. 1.2 Annual Meetings. The annual |
|
| June 1, 2022 |
EX-99.1 3 a060122johnsonmillsxkline.htm EX-99.1 Owens & Minor Elects Rita Johnson-Mills and Terri Kline to Board of Directors Owens & Minor Elects Rita Johnson-Mills (left) and Terri Kline (right) to Board of Directors RICHMOND, Va. – June 1, 2022 – Owens & Minor, Inc. (NYSE: OMI), a leading global healthcare solutions company, today announced that Rita Johnson-Mills and Terri Kline have been elec |
|
| June 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2022 Owens & Minor, Inc. |
|
| May 27, 2022 |
Conflict Minerals Report for the year ended December 31, 202 EXHIBIT 1.01 Owens & Minor, Inc. Conflict Minerals Report For the Year Ended December 31, 2021 I. Introduction This Conflict Minerals Report (?Report?) by Owens & Minor, Inc. is for the period from January 1, 2021 to December 31, 2021 (?Reporting Period?). Unless the context otherwise indicates, ?Owens & Minor,? ?Company,? ?we,? ?us,? and ?our? mean Owens & Minor, Inc. and its consolidated subsidi |
|
| May 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report OWENS & MINOR, INC. (Exact name of registrant as specified in its charter) Virginia 001-9810 54-1701843 (State or other jurisdiction of incorporation (Commission File Number) (IRS Employer Identification No.) 9120 Lockwood Boulevard, Mechanicsville, Virginia 23116 (Address of principal exe |
|
| May 23, 2022 |
1 Confidential & Proprietary to Owens & Minor, Inc. UBS Global Healthcare Conference May 23, 2022 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This presentation contains certain ' |
|
| May 23, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2022 Owens & Minor, Inc. |
|
| May 5, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2022 Owens & Minor, Inc. |
|
| May 5, 2022 |
Owens & Minor, Inc. Summary Apria Adjusted EBITDA Reconciliation (unaudited) In connection with Owens & Minor, Inc.'s (the "Company") acquisition of Apria, Inc. ("Apria") on March 29, 2022, we have revised Apria?s historical presentation and calculation of adjusted EBITDA to reflect our presentation and calculation of adjusted EBITDA. Accordingly, the following items were deducted from the histori |
|
| May 4, 2022 |
List of Guarantor Subsidiaries Exhibit 22.1 Owens & Minor, Inc. List of Guarantor Subsidiaries The following table lists the guarantors, issuers, or co-issuers of Owens & Minor, Inc.'s 2024 Notes as of March 31, 2022: Entity: Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard, Inc. O&M Byram Holding, GP Byram Holdings I, Inc. Byram |
|
| May 4, 2022 |
Filing Fee Table (filed herewith) Exhibit 107 Calculation of Filing Fee Tables Form S-8 Owens & Minor, Inc. Table 1 - Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $2 par value Other(2) 3,216,759(3) $37.48(2) $120,548,043.53 .0000927 $11,174.80 |
|
| May 4, 2022 |
Amendment No. 3 To the Owens & Minor, Inc. 2018 Stock Incentive Plan This AMENDMENT NO. 3 (this ?Amendment?) to the Owens & Minor, Inc. 2018 Stock Incentive Plan (as amended, the ?Plan?) is effective as of April 29, 2022 (the ?Amendment Effective Date?). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the Plan. WHEREAS, Owens & Minor, Inc., |
|
| May 4, 2022 |
List of Subsidiaries Pledged as Collateral Exhibit 22.2 Owens & Minor, Inc. List of Subsidiaries Pledged as Collateral The following table lists the pledged subsidiaries of Owens & Minor, Inc.?s 2024 Notes that constitute collateral (together, "the Collateral Group") as of March 31, 2022: Entity Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyar |
|
| May 4, 2022 |
As filed with the Securities and Exchange Commission on May 4, 2022 As filed with the Securities and Exchange Commission on May 4, 2022 Registration No. |
|
| May 4, 2022 |
Execution Version #95537553v12 JOINDER TO CREDIT AGREEMENT, AMENDMENT NO. 2 TO CREDIT AGREEMENT, AMENDMENT NO. 1 TO SECURITY AGREEMENT AND AMENDMENT NO. 1 TO GUARANTY THIS JOINDER TO CREDIT AGREEMENT, AMENDMENT NO. 2 TO CREDIT AGREEMENT, AMENDMENT NO. 1 TO SECURITY AGREEMENT AND AMENDMENT NO. 1 TO GUARANTY (this ?Amendment?), dated as of March 29, 2022, is entered into among OWENS & MINOR, INC., a |
|
| May 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 Owens |
|
| May 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2022 Owens & Minor, Inc. |
|
| May 3, 2022 |
Owens & Minor Reports First Quarter 2022 Financial Results ?Continued revenue growth in both segments, highlighted by 26% growth in Patient Direct ?Q1 GAAP EPS of $0. |
|
| May 3, 2022 |
1 Confidential & Proprietary to Owens & Minor, Inc. First Quarter 2022 Supplemental Earnings Slides May 3, 2022 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This presentation cont |
|
| April 29, 2022 |
AMENDED AND RESTATED BYLAWS OF OWENS & MINOR, INC. ARTICLE I Meetings of Shareholders 1.1 Places of Meetings. All meetings of the shareholders shall be held at such place either within or without the Commonwealth of Virginia, or at no physical place but solely by means of remote communication, in each case as from time to time may be fixed by the Board of Directors. 1.2 Annual Meetings. The annual |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2022 Owens & Minor, Inc. |
|
| April 21, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2022 Owens & Minor, Inc. |
|
| April 21, 2022 |
Owens & Minor, Inc. Summary Segment Information (unaudited) (dollars in thousands) The unaudited reclassified summary segment financial information below is provided to reflect the realignment of the Company's reporting segments effective during the first quarter of 2022. The Company did not operate under the realigned structure for any of these prior periods and will begin to report comparative r |
|
| April 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of |
|
| March 29, 2022 |
Exhibit 99.1 INDEX TO FINANCIAL STATEMENTS Audited Consolidated Financial Statements of Apria, Inc. Report of Independent Registered Public Accounting Firm (PCAOB ID 34) 2 Consolidated Balance Sheets as of December 31, 2021 and December 31, 2020 4 Consolidated Statements of Income for the years ended December 31, 2021, December 31, 2020 and December 31, 2019 5 Consolidated Statements of Stockholde |
|
| March 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report: (Date of earliest event reported) March 29, 2022 OWENS & MINOR, INC. |
|
| March 29, 2022 |
Exhibit 10.1 Execution Version TERM LOAN CREDIT AGREEMENT Dated as of March 29, 2022 among OWENS & MINOR, INC., as the Parent Borrower, OWENS & MINOR DISTRIBUTION, INC., OWENS & MINOR MEDICAL, INC., BARISTA ACQUISITION I, LLC, BARISTA ACQUISITION II, LLC O&M HALYARD, INC., BYRAM HEALTHCARE CENTERS, INC., and APRIA, INC. as Borrowers, CERTAIN OTHER BORROWERS AS MAY BECOME PARTIES HERETO FROM TIME T |
|
| March 29, 2022 |
Exhibit 4.4 This FIRST SUPPLEMENTAL INDENTURE, (this ?Supplemental Indenture?) dated as of March 29, 2022, by and among the parties that are signatories hereto as Guarantors (the ?Guaranteeing Entities? and each a ?Guaranteeing Entity?), Owens & Minor, Inc., as Issuer, and Regions Bank, a national banking association, as Trustee under the Indenture referred to below. W I T N E S S E T H: WHEREAS, |
|
| March 29, 2022 |
Exhibit 4.3 This SEVENTH SUPPLEMENTAL INDENTURE (this ?Seventh Supplemental Indenture?), entered into as of March 29, 2022, among Owens & Minor, Inc., a Virginia corporation (the ?Company?), the guarantors signatory hereto (the ?Additional Guarantors? and each a ?Additional Guarantor?) and Regions Bank, as trustee (as successor trustee to U.S. Bank National Association, the ?Trustee?). RECITALS WH |
|
| March 29, 2022 |
Exhibit 99.3 Owens & Minor, Inc. Completes Acquisition of Apria, Inc. Closure of previously announced acquisition combines complementary Byram and Apria product portfolios to enhance patient service through the hospital and into the home Expansion of Owens & Minor?s presence in the rapidly growing home healthcare market accelerates growth platform and diversifies company financials RICHMOND, Va.?M |
|
| March 29, 2022 |
OWENS & MINOR, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.2 OWENS & MINOR, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On March 29, 2022 (the Closing Date), Owens & Minor, Inc. (Owens & Minor, OMI, we, us, our or the Company) completed the acquisition of Apria, Inc., a Delaware corporation (Apria), pursuant to the Agreement and Plan of Merger, dated as of January 7, 2022, by and among the Company, Apria and StoneOak Merge |
|
| March 29, 2022 |
Exhibit 4.5 Execution Version Supplemental Indenture to Add Guarantors FIRST SUPPLEMENTAL INDENTURE, (this ?Supplemental Indenture?) dated as of March 29, 2022, by and among the parties that are signatories hereto as Guarantors (the ?Guaranteeing Entities? and each a ?Guaranteeing Entity?), Owens & Minor, Inc., as Issuer, and Regions Bank, a national banking association, as Trustee under the Inden |
|
| March 29, 2022 |
EX-4.1 2 d339132dex41.htm EX-4.1 Exhibit 4.1 OWENS & MINOR, INC. AND REGIONS BANK, as Trustee 6.625% Senior Notes due 2030 INDENTURE Dated as of March 29, 2022 Table of Contents Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE SECTION 1.1. Definitions 1 SECTION 1.2. Other Definitions 51 SECTION 1.3. [Reserved] 54 SECTION 1.4. Rules of Construction 54 ARTICLE II THE NOTES SECTION 2.1. Form |
|
| March 29, 2022 |
EX-10.2 7 d339132dex102.htm EX-10.2 Exhibit 10.2 EXECUTION VERSION FOURTH AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT This FOURTH AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT (this “Amendment”), dated as of March 29, 2022, is entered into by and among the following parties: (i) O&M FUNDING LLC, as Borrower (the “Borrower”); (ii) OWENS & MINOR MEDICAL, INC., as initial Servicer (the “Servi |
|
| March 23, 2022 |
Owens & Minor Announces Upsize and Pricing of $600 Million of Senior Notes due 2030 Exhibit 99.1 Owens & Minor Announces Upsize and Pricing of $600 Million of Senior Notes due 2030 RICHMOND, VA ? (Business Wire) ? March 23, 2022 - Owens & Minor, Inc. (NYSE:OMI) (the ?Company?) announced today the upsize and pricing of its private offering (the ?Offering?) of $600 million aggregate principal amount of its 6.625% senior notes due 2030 (the ?Notes?), representing an increase of $100 |
|
| March 23, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 23, 2022 OWENS & MINOR, INC. (Exact name of Registrant as specified in charter) Virginia 001-09810 54-1701843 (State or other jurisdiction of incorporation) (Commission file num |
|
| March 18, 2022 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On January 7, 2022, Owens & Minor, Inc. (?we,? ?our,? ?us,? ?the company?, ?our company? and ?Owens & Minor?) and StoneOak Merger Sub Inc., our indirect wholly owned subsidiary ( ?Merger Sub?) entered into an Agreement and Plan of Merger (the ?Acquisition Agreement?) with Apria, Inc. (?Apria?) pursuant to which Merger Sub wi |
|
| March 18, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 18, 2022 OWENS & MINOR, INC. (Exact name of Registrant as specified in charter) Virginia 001-09810 54-1701843 (State or other jurisdiction of incorporation) (Commission file num |
|
| March 18, 2022 |
OWENS & MINOR ANNOUNCES LAUNCH OF SENIOR NOTES OFFERING Exhibit 99.1 OWENS & MINOR ANNOUNCES LAUNCH OF SENIOR NOTES OFFERING RICHMOND, VA - (Business Wire) - March 18, 2022 - Owens & Minor, Inc. (NYSE:OMI) (the ?Company?) announced today that it has launched a private offering (the ?Offering?) of $500 million aggregate principal amount of senior notes due 2030 (the ?Notes?), subject to customary and market conditions. Unless the Acquisition (as defined |
|
| March 17, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confid |
|
| March 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of |
|
| March 15, 2022 |
1 Confidential & Proprietary to Owens & Minor, Inc. Barclays Global Healthcare Conference March 15, 2022 2 Confidential & Proprietary to Owens & Minor, Inc. Safe Harbor This presentation contains certain ?forward looking? statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regar |
|
| March 15, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2022 Owens & Minor, Inc. |
|
| March 10, 2022 |
OMI / Owens & Minor, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Owens & Minor, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 690732102 (CUSIP Number) February 28, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc |
|
| March 1, 2022 |
OWENS & MINOR, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT This RESTRICTED STOCK UNIT AWARD AGREEMENT (the ?Agreement?) dated [Grant Date], between OWENS & MINOR, INC., a Virginia corporation (the "Company"), and [Participant Name] ("Participant"), is made pursuant and subject to the provisions of the Company's 2018 Stock Incentive Plan (as amended, the "Plan"). All capitalized terms used herein th |
|
| March 1, 2022 |
OWENS & MINOR, INC. 2022 PERFORMANCE STOCK UNIT AWARD AGREEMENT THIS 2022 PERFORMANCE STOCK UNIT AWARD AGREEMENT (?Agreement?) dated as of Grant Date between Owens & Minor, Inc., a Virginia corporation (the ?Company?), and Participant Name (?Participant?) is made pursuant to and subject to the provisions of the Company's 2018 Stock Incentive Plan (as amended, the ?Plan?). All capitalized terms use |
|
| March 1, 2022 |
OWENS & MINOR, INC. Restricted Stock Agreement THIS RESTRICTED STOCK AGREEMENT (the ?Agreement?) dated Grant Date between OWENS & MINOR, INC., a Virginia corporation (the "Company"), and Participant Name ("Participant"), is made pursuant and subject to the provisions of the Company's 2018 Stock Incentive Plan (as amended, the "Plan"). All capitalized terms used herein that are not otherwise define |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2022 Owens & Minor, Inc. |
|
| February 28, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2022 Owens & Minor, Inc. (Exact Name of Registrant as Specified in its Charter) Virginia 001-09810 54-1701843 (State or other jurisdiction of incorporation or organizatio |
|
| February 28, 2022 |
Exhibit 99.1 Investor Presentation February 28, 2022 ? March 1, 2022 Confidential & Proprietary to Owens & Minor, Inc. 1 This presentation contains certain ?forward looking? statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding the proposed transaction with Apria, Inc. ( |
|
| February 24, 2022 |
EX-99.1 3 a0220222omnewdirectorv2fi.htm EX-99.1 Owens & Minor Selects Kenny Gardner to Join Board of Directors DaVita Inc. officer joins as part of multi-year director succession process Owens & Minor Selects Kenny Gardner to Join Board of Directors RICHMOND, VA – February 24, 2022 – Owens & Minor, Inc. (NYSE: OMI), a leading global healthcare solutions company, today announced the selection of Ke |
|
| February 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2022 Owens & Minor, Inc. |
|
| February 24, 2022 |
AMENDED AND RESTATED BYLAWS OF OWENS & MINOR, INC. ARTICLE I Meetings of Shareholders 1.1Places of Meetings. All meetings of the shareholders shall be held at such place either within or without the Commonwealth of Virginia, or at no physical place but solely by means of remote communication, in each case as from time to time may be fixed by the Board of Directors. 1.2Annual Meetings. The annual m |
|
| February 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the year ended December 31, 2021 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 1-9810 OWENS & MINOR, INC. (Exact name of regi |
|
| February 23, 2022 |
Exhibit 21.1 Subsidiaries of Registrant Subsidiary State of Incorporation/Organization Country Assumed Name 500 Expressway Drive South LLC Delaware USA Access Diabetic Supply, L.L.C. Florida USA AOM Healthcare Solutions Access Respiratory Supply Inc Florida USA American Contract Systems, Inc. Minnesota USA AVID Medical, Inc. Delaware USA Barista Acquisition I, LLC Virginia USA Barista Acquisition |
|
| February 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2022 Owens & Minor, Inc. |
|
| February 23, 2022 |
List of Subsidiaries Pledged as Collateral Exhibit 22.2 Owens & Minor, Inc. List of Subsidiaries Pledged as Collateral The following table lists the pledged subsidiaries of Owens & Minor, Inc.?s 2024 Notes that constitute collateral (together, "the Collateral Group") as of December 31, 2021: Entity Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Hal |
|
| February 23, 2022 |
Description of Securities - filed herewith EX-4.10 2 exhibit410-descriptionofst.htm EX-4.10 DESCRIPTION OF THE COMPANY’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a brief description of the common stock, $2.00 par value per share (the “Common Stock”), of Owens & Minor, Inc. (the “Company,” “we,” “us,” and “our”), which is the only security of the Company registered pursuant to Sect |
|
| February 23, 2022 |
Owens & Minor Reports Fourth Quarter and Full Year 2021 Financial Results •Strong Finish to a Year with Robust Growth and Record Setting Profitability •Company Reaffirms 2022 Guidance •Acquisition of Apria Remains on Track RICHMOND, VA – February 23, 2022 – Owens & Minor, Inc. |
|
| February 23, 2022 |
List of Guarantor Subsidiaries Exhibit 22.1 Owens & Minor, Inc. List of Guarantor Subsidiaries The following table lists the guarantors, issuers, or co-issuers of Owens & Minor, Inc.'s 2024 Notes as of December 31, 2021: Entity: Owens & Minor, Inc. Owens & Minor Distribution, Inc. Owens & Minor Medical, Inc. Barista Acquisition I, LLC Barista Acquisition II, LLC O&M Halyard, Inc. O&M Byram Holding, GP Byram Holdings I, Inc. Byr |
|
| February 23, 2022 |
Fourth Quarter and Full Year 2021 Supplemental Earnings Slides February 23, 2022 2 Safe Harbor This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. |
|
| February 23, 2022 |
Execution Version Error! Unknown document property name. AMENDMENT NO. 1 TO CREDIT AGREEMENT THIS AMENDMENT NO. 1 TO CREDIT AGREEMENT (this ?Agreement?), dated as of [?] (the ?Amendment Effective Date?), is entered into among OWENS & MINOR DISTRIBUTION, INC., a Virginia corporation (?Distribution?), OWENS & MINOR MEDICAL, INC., a Virginia corporation (?Medical?), BARISTA ACQUISITION I, LLC, a Virg |
|
| February 23, 2022 |
[***] ? Certain identified information has been excluded from this exhibit because it is both not material and is treated by Company as private or confidential. |
|
| February 10, 2022 |
OMI / Owens & Minor, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 15)* Name of issuer: Owens & Minor Inc. Title of Class of Securities: Common Stock CUSIP Number: 690732102 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ? |
|
| February 8, 2022 |
OMI / Owens & Minor, Inc. / DIMENSIONAL FUND ADVISORS LP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Owens & Minor Inc (Name of Issuer) Common Stock (Title of Class of Securities) 690732102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sche |
|
| February 4, 2022 |
OMI / Owens & Minor, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Owens & Minor, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 690732102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc |
|
| February 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2022 Owens & Minor, Inc. |
|
| February 1, 2022 |
Amended and Restated Bylaws of the Company effective January 31, 2022 AMENDED AND RESTATED BYLAWS OF OWENS & MINOR, INC. ARTICLE I Meetings of Shareholders 1.1Places of Meetings. All meetings of the shareholders shall be held at such place either within or without the Commonwealth of Virginia, or at no physical place but solely by means of remote communication, in each case as from time to time may be fixed by the Board of Directors. 1.2Annual Meetings. The annual m |
|
| January 10, 2022 |
Exhibit 99.1 OWENS & MINOR, INC. SIGNS DEFINITIVE AGREEMENT TO ACQUIRE APRIA, INC. Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth RICHMOND, Va. and INDIANAPOLIS ?(BUSINESS WIRE) ? Jan. 10, 2022? Owens & Minor, Inc. (?Owens & Minor?) (NYSE: OMI) and Apria, In |
|
| January 10, 2022 |
EX-99.2 4 d286913dex992.htm EX-99.2 ACQUISITION OF APRIA, INC. JANUARY 10, 2022 Exhibit 99.2 Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This presentation contains certain ''forward-looking'' statements made pursuant to the Safe H |
|
| January 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report: January 10, 2022 OWENS & MINOR, INC. |
|
| January 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report: January 7, 2022 OWENS & MINOR, INC. |
|
| January 10, 2022 |
Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among OWENS & MINOR, INC., STONEOAK MERGER SUB INC. and APRIA, INC. Dated as of January 7, 2022 TABLE OF CONTENTS Page ARTICLE I THE TRANSACTIONS SECTION 1.01 The Merger 2 SECTION 1.02 Closing 2 SECTION 1.03 Effective Time 2 SECTION 1.04 Effects of the Merger 2 SECTION 1.05 Certificate of Incorporation and Bylaws of the Surviving Co |
|
| December 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2021 Owens & Minor, Inc. |
|
| November 30, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits ~ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2021 Owens & Minor, Inc. |
|
| November 30, 2021 |
Bank of America Leveraged Finance Conference November 30, 2021 2 Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. |
|
| November 3, 2021 |
EX-99.2 3 a3q21supplementalslidesv.htm EX-99.2 3rd Quarter 2021 Earnings Supplemental Slides November 3, 2021 3rd Quarter 2021 Earnings – November 3, 20212 This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This presentation contains certain ''forwa |
|
| November 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-9810 Ow |
|
| November 3, 2021 |
OWENS & MINOR, INC. Restricted Stock Agreement THIS RESTRICTED STOCK AGREEMENT (the ?Agreement?) dated Grant Date between OWENS & MINOR, INC., a Virginia corporation (the "Company"), and Participant Name ("Participant"), is made pursuant and subject to the provisions of the Company's 2018 Stock Incentive Plan (as amended, the "Plan"). All capitalized terms used herein that are not otherwise define |
|
| November 3, 2021 |
Owens & Minor Reports 3rd Quarter Financial Results ?Year-over-Year Revenue Growth of over 14% ?Continued Expansion of Operating Margin in Global Solutions ?Narrows Range for 2021 guidance and Affirms previously announced 2022 guidance RICHMOND, VA ? November 3, 2021 ? Owens & Minor, Inc. |
